Please login to the form below
Delinia
This page shows the latest Delinia news and features for those working in and with pharma, biotech and healthcare.
Syncona launches another cell therapy company, Treg specialist Quell
Previous deals saw Celgene swoop on Delinia and its Treg therapies for autoimmune conditions, paying $300m upfront for the company, while Eli Lilly paid $150m for co-development rights to a ... Delinia’s DEL106 acts as an interleukin-2 (IL-2) mutein Fc
Latest news
-
Celgene pays $300m upfront for immunology start-up Delinia
Celgene has made another bolt-on acquisition, paying $300m upfront and $475m in milestones for Delinia and its immunology and inflammation programmes. ... The scale of the deal is eye-opening given that Delinia's lead candidate is still in preclinical
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Latest Intelligence
-
Deal Watch January 2017
960. Valeant. Sanpower Group. Divestment. Dendreon equity interest. 820. Delinia. Celgene.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest appointments
-
BMS appoints Saurabh Saha as senior VP, global head of translational medicine
chief executive officer of Delinia until its sale to Celgene.
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Featured jobs
- Client Services Director- Flexible Working
-
Negotiable
-
Senior Medical Writer
-
Competitive salary plus benefits
- Account Manager – Healthcare advertising
-
Salary TBC
-
Events Executive
-
DOE
-
Account Director – UK Office
-
Excellent salary and benefits
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
Subscribe to our email news alerts
- Novartis eyes potential new indication for Cosentyx
- J&J's Tremfya filed for approval in US for psoriatic arthritis
- Envision Pharma Group relocates to support expansion
- Biogen loses another pipeline drug to toxicity concerns
- Half of European cancer drug trials ‘biased’, says BMJ
- AZ, Merck’s Lynparza scores market-expanding clinical success
PMHub
OUTiCO
Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...
Latest intelligence
- Report: Customer experience, shaping digital healthcare
- In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
- Encouraging signs in biomarker R&D
- The cancer immunotherapy firms ramping-up biomarker R&D...
- Programmatic methodology and why you should be using it
- What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...
Quick links
Infographics
